Navigation Links
Lumping a Lumpectomy Difficult for One-third of Women

Nearly a third of women who under go lumpectomy feel that the outcome is a significant compromise on cosmetics, affecting the way// their breasts look, a recent survey has revealed.

The annual American Society of Plastic Surgeons (ASPS) Plastic Surgery 2006 conference in San Francisco was witness to the findings of the survey, which inferred that the majority of unhappy lumpectomy patients would explore the possibility of reconstructive breast surgery.

Among 28 percent of the patients who expressed unhappiness with the appearance of their breasts post-lumpectomy, nearly half of the lot were extremely put-off with the appearance, and were seriously debating a cosmetic chest-lift surgery.

Dr Howard Wang, co-author of the study said, “Patients should know their options and understand that just because they undergo a lumpectomy to save their breast does not mean they will be happy with the cosmetic outcome."


'"/>




Page: 1

Related medicine news :

1. HRT: A Difficult Decision
2. Help For Kids With Difficulty In Sleeping
3. Asthma Patients With Sinusitis More Difficult To Treat
4. Difficult Pregnancy Linked to Premature Heart Problems
5. Sperm Retrieval, Difficult in Klinefelter’s Syndrome Patients after 35 Year
6. Premature Babies Give It Their Best Shot To Overcome Difficulty
7. Older Women Who Are Avid Watchers of the Tube Have Cognitive Difficulties
8. Maternal Difficulties Increase Risk of Behavior Problems in Children
9. TV Viewing Might Increase The Risk Of Sleeping Difficulties In Children’
10. Female Genital Mutilation May Lead To Difficult Childbirth:Rep
11. Obesity Makes Treatment of HCV Difficult
Post Your Comments:
(Date:11/20/2008)... Therapeutics Inc., a leader,in the development o...million,in additional funding to expand the devel...oFx is a diagnostic test that helps physicians sel...or cancer patients. New investor,Longitude Vent...y existing,investors Adams Capital Management, Qu...
(Date:11/20/2008)...supported clean-water,campaign known as the TAP P...ufacturer, The Watergeeks Laboratories, will becom... the third year of this award-winning, life-saving... children around the world. , Beginning Nov...donate a,percentage of the on-line retail price o...
(Date:11/20/2008)...olutions, the leader in,driving peak Health Infor...ology and management solutions, was recognized by ... "Technology Company of the Year" at the 16th,Ent... Annual Gala honors the,region,s top technology a...e,than 1200 business leaders attended the black t...
(Date:11/20/2008)...investor group in Trinity,Biotech plc (Nasdaq: ...of,diagnostic products whose shares are traded in...AQ, is encouraged that Clint Severson has joined t...ing on the news, Tom Reidy stated, "We are delight...nt director, bringing the total of independent,di...
Breaking Medicine News(10 mins):Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 3Health News:Precyse Solutions Honored as 'Technology Company of the Year' 2Health News:Investor Group Commends Clint Severson for Joining Trinity Biotech's Board of Directors 2
... developed a computerized garment that they say ca...a, depression and schizophrenia . The high-tech ga...t, breathing rate, blood pressure, skin temperatur...osture, reported online edition of the Daily Mail....
...t have to think twice before indulging in their fa... new range of low-sugar sweets and chocolates inc...nging tastes of health-conscious consumers. In add...aunching low-calorie versions of its Maynards Wine...
...g weight to get into shape for her new movie 'Knoc...super-in-shape reporter' in her new movie , had to...s that she didn't like it one bit, and insists tha...rdest things she's ever had to do, especially as s...
...ted majors are more likely to have poorer quality ...major, according to a research abstract that will...nual Meeting of the Associated Professional Sleep ... by Aryn Karpinski of West Virginia University, fo...
Other Medicine News:Health News:Researchers Have Developed Computerized Garment to Diagnose Mental Illness 2Health News:Cadbury to Introduce Healthier, Low Calorie Sweets to Health Conscious Consumers 2
(Date:11/20/2008)... , PHILADELPHIA, Nov. 20 /PRNewswire-FirstCal...d that the United States Food and Drug Administrat...A(R) (eltrombopag) for the treatment of thrombocyt...) thrombocytopenic purpura (ITP) who have had an i...bulins or splenectomy. The approval is a significa...
(Date:11/20/2008)..., Nov. 20 Duska Therapeu... today that it has submitted its,pivotal Phase 3 ...Special,Protocol Assessment (SPA) procedure with ... Subject to securing an agreement with the FDA..., double-blind, placebo-controlled and randomized ...
(Date:11/19/2008)...ov. 19 Posit Science Corporation,...Society for Neuroscience,Annual Conference in Was...raining may benefit Baby Boomers. The computerize...M) uses adaptive exercises that target auditory an...o drive generalized,improvements in cognition by ...
(Date:11/19/2008)...v. 19 Isogen, a contract developme...ling, today announced the first,phase launch of i...ed to,specifically address the process, facility ...e $2 billion highly-niched, low-volume clinical an...egment. , Companies can invest over $100 mi...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2NPS Pharmaceuticals Announces Senior Management Changes 3521 1NPS Pharmaceuticals Announces Senior Management Changes 3521 2NPS Pharmaceuticals Announces Senior Management Changes 3521 3NeoStem to Present at Third Annual Stem Cell Summit in New York City 3517 1NeoStem to Present at Third Annual Stem Cell Summit in New York City 3517 2NeoStem to Present at Third Annual Stem Cell Summit in New York City 3517 3Acuo Technologies 28R 29 Announces a Fully Integrated XDS I Solution 12711 1Acuo Technologies 28R 29 Announces a Fully Integrated XDS I Solution 12711 2VIA Pharmaceuticals to Present at Susquehanna and Rodman 26 Renshaw Conferences on March 4 2008 12707 1
...r 14, 2007 - ArQule, Inc.,(NASDAQ: ARQL) today ann...ogy (ASCO) has accepted for oral presentation the,...alation Study of,ARQ 197, a Selective Inhibitor of...lid Tumors) at the 43rd ASCO Annual Meeting, June,...ribe findings,from a Phase 1 trial with ARQ 197, a...
...Newswire-FirstCall/ --,Medivation, Inc. today anno...double-blinded, placebo-controlled Phase 2 efficac...derate Alzheimer,s,disease demonstrated that patie...ed compared to patients taking placebo on all,five...ive function,memory, ability to perform tasks of ...
Other Medicine Technology:ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 2Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 3Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference 4
The GelAir™ dryer is a component of the GelAir drying system. Supplied as a 230 V, 50 Hz gel drying oven.
The 1000-90 is the most versatile power supply in its class. Capable of producing up to 1000 volts or 1250 milliamps or 325 watts, it easily outperforms the competition. No other 1000 volt power supp
... to IEF to DNA sequencing, Thermo Series 90 high v...trophoretic applications. These power supplies ca... constant power operating modes, with automatic cr...e Series 90 power supplies, four sets of output co...
The MAX POWER Programmable Power Supply are high-performance, easy to operate instruments which can handle virtually any application from high voltage electrophoresis to high current blotting. It is
Medicine Products: